6640-Specimen Validity and Drug of Abuse of Abuse Reagent Supplies for the Minneapolis VA Health Care System
Key Takeaways
- Set-aside for No Set Aside businesses
- Work to be performed in Saint Paul, MN
- Industry: In-Vitro Diagnostic Substance Manufacturing
Contract Details
- Notice ID
- 36C26326Q0650_1
- Opportunity Type
- Special Notice
- Sub-Agency
- VETERANS AFFAIRS, DEPARTMENT OF
- Office
- NETWORK CONTRACT OFFICE 23 (36C263)
- Posted Date
- Thursday, August 27, 2026
- Response Deadline
- Friday, September 11, 2026
- PSC Code
- 6640
- Set-Aside
- No Set Aside
- Place of Performance
- Saint Paul, MN, 55101
- Status
- Active
Description
The Department of Veterans Affairs, Network Contracting Office 23 intends to award a sole source contract under the authority of FAR 6.103-1/FAR Overhaul 12.102(a) Only one responsible source and no other supplies will satisfy agency requirements, to Siemens Healthcare Diagnostics, Inc. for FDA approved specimen validity and Fentanyl reagents. These reagents will be used to verify the validity of specimens, including nitrite and creatinine assays, as well as perform Fentanyl testing in our highly specialized Forensic Toxicology Laboratory. This notice of intent is not a request for quotations; interested parties may express their interest by providing a capabilities statement no later than September 11, 2026, at 16:00 CT. The capabilities statement must provide clear and unambiguous eviden
Why This Opportunity Matters
VETERANS AFFAIRS, DEPARTMENT OF is seeking responses for in-vitro diagnostic substance manufacturing with a set-aside for No Set Aside businesses in Saint Paul, MN. This set-aside designation means eligible businesses face reduced competition from larger firms.
Similar Opportunities
Browse Related
Looking for more opportunities?
Browse our full directory of government contracts
